| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 07/11/2006 | CA2280100C Alkynyl-substituted camptothecins and process for their preparation |
| 07/11/2006 | CA2274074C Novel compounds with analgesic effect |
| 07/11/2006 | CA2269810C N-substituted 2-cyanopyrrolidines |
| 07/11/2006 | CA2262566C Benzamidine derivatives and the use thereof as medicaments with ltb4-antagonistic effect |
| 07/11/2006 | CA2260999C Heterocyclic compounds, their production and use in tyrosine kinase inhibition |
| 07/11/2006 | CA2252773C Taste masked pharmaceutical compositions |
| 07/11/2006 | CA2246783C Mcbi analogs of cc-1065 and the duocarmycins |
| 07/11/2006 | CA2244870C N,n-disubstituted amic acid derivatives |
| 07/11/2006 | CA2244256C Antipruritic |
| 07/11/2006 | CA2238065C Medicament for circadian rhythm sleep disorder |
| 07/11/2006 | CA2231750C Hydrolysis-promoting taxane hydrophobic derivatives |
| 07/11/2006 | CA2227984C Aza-anthracyclinone derivatives |
| 07/11/2006 | CA2215233C Terminal carboxy or tetrazole groups containing dialkyl ethers |
| 07/11/2006 | CA2208630C 4-amino-2-ureidopyrimidine-5-carboxamides, processes for their preparation, pharmaceuticals comprising these compounds, and their use |
| 07/11/2006 | CA2206532C Novel amidinonaphthyl derivative or salt thereof |
| 07/11/2006 | CA2205564C Pharmaceutical compositions comprising nitric oxide-releasing biopolymers |
| 07/11/2006 | CA2198751C Dihydro-2,3-benzodiazepine derivatives |
| 07/11/2006 | CA2198210C Non self-inactivating, expression targeted retroviral vectors |
| 07/11/2006 | CA2182273C L-nucleosides for the treatment of hepatitis b-virus and epstein-bar virus |
| 07/11/2006 | CA2176463C Hu-b1.219, a novel human hematopoietin receptor |
| 07/11/2006 | CA2168447C Compounds and methods for inhibition of hiv and related viruses |
| 07/11/2006 | CA2163244C Quinoline derivatives as leukotriene antagonists |
| 07/11/2006 | CA2158609C 5 .alpha.-reductase inhibitors |
| 07/11/2006 | CA2157921C Pharmaceutical compositions comprising paracetamol and l-cysteine or a precursor thereof |
| 07/11/2006 | CA2130867C An aerosol container and the use of an aerosol container |
| 07/11/2006 | CA2129998C Improved amino acid solutions for treatment of peritoneal dialysis patients |
| 07/11/2006 | CA2126354C Use of 5-ht4 modulators for the manufacture of a medicament for the treatment of the bladder diseases |
| 07/11/2006 | CA2125830C Heteroaryl cinnamic acids as inhibitors of leukotriene biosynthesis |
| 07/11/2006 | CA2125824C Heteroaryl coumarins as inhibitors of leukotriene biosynthesis |
| 07/11/2006 | CA2102912C Application system and method for treating warts |
| 07/11/2006 | CA2090584C Steroids having a methylene lactone group at position 17, process for preparing the same and their intermediates, use of the same as drugs and pharmaceutical compositions comprising the same |
| 07/06/2006 | WO2006072113A2 Therapeutic composition |
| 07/06/2006 | WO2006072093A2 Treatment of graft-versus-host disease and leukemia with beclomethasone dipropionate and prednisone |
| 07/06/2006 | WO2006072070A2 Pharmaceutical formulations of gallium salts |
| 07/06/2006 | WO2006072054A1 Zinc-containing treatments for hyperphosphatemia |
| 07/06/2006 | WO2006072001A2 Active compositions and methods |
| 07/06/2006 | WO2006071997A2 Treatment for cutaneous metastases |
| 07/06/2006 | WO2006071995A1 Serine amino acid derived prodrugs of propofol, compositions, uses and crystalline forms thereof |
| 07/06/2006 | WO2006071988A1 Thienopyrimidine derivatives as phosphodiesterase 10 inhibitors |
| 07/06/2006 | WO2006071966A2 Rapamycin compounds in the treatment of neurofibromatosis type 1 |
| 07/06/2006 | WO2006071958A1 Compounds useful as chemokine receptor antagonists |
| 07/06/2006 | WO2006071955A2 Glufosfamide combination therapy |
| 07/06/2006 | WO2006071897A2 Treatment of macular degeneration with lonidamine |
| 07/06/2006 | WO2006071862A2 Polymorphs of 1-(2-methylpropyl)-1h-imidazo[4,5-c][1,5]naphthyridin-4-amine ethanesulfonate |
| 07/06/2006 | WO2006071848A2 Glycolipids and analogues thereof as antigens for nk t cells |
| 07/06/2006 | WO2006071844A2 Oxygen-impervious packaging and methods for storing thyroid hormone |
| 07/06/2006 | WO2006071819A1 [1h-pyrazolo[3, 4-d]pyrimidin-4-yl]-piperidine or -piperazine compounds as serine-theoronine kinase modulators (p70s6k, atk1 and atk2) for the treatment of immunological, inflammatory and proliferative diseases |
| 07/06/2006 | WO2006071812A2 Platinum iv complex inhibitor |
| 07/06/2006 | WO2006071759A2 Fluorescent pyrazine derivatives and methods of using the same in assessing renal function |
| 07/06/2006 | WO2006071752A1 Azolopyrimidine-based inhibitors of dipeptidyl peptidase iv and methods |
| 07/06/2006 | WO2006071694A1 Visco-supplement composition and methods |
| 07/06/2006 | WO2006071659A1 Delivery of h2 antagonists |
| 07/06/2006 | WO2006071644A1 Selective inhibitors of erk protein kinases and uses therof |
| 07/06/2006 | WO2006071601A2 Therapeutic compositions for intranasal administration of ketorolac |
| 07/06/2006 | WO2006071564A2 Aminium salts of 1,2,3-triazoles as prodrugs of drugs including antiviral agents |
| 07/06/2006 | WO2006071538A2 Substituted biaryl analogues |
| 07/06/2006 | WO2006071491A1 Pharmaceutical formulation of decitabine |
| 07/06/2006 | WO2006071471A2 2-(2 or 4-substituted aryloxy)-phenol derivatives as antibacterial agents |
| 07/06/2006 | WO2006071459A2 System and method for power management in mobile units |
| 07/06/2006 | WO2006071351A2 Synergistic effect of amlodipine and atorvastatin on aortic endothelial cell nitric oxide release |
| 07/06/2006 | WO2006071342A2 Cardiovascular compositions |
| 07/06/2006 | WO2006071274A2 Leuprolide acetate and acetylcholinesterase inhibitors or nmda receptor antagonists for the treatment of alzheimer’s disease |
| 07/06/2006 | WO2006071186A1 Use of gabab receptor agonists |
| 07/06/2006 | WO2006071185A1 New use of gabab receptor agonists |
| 07/06/2006 | WO2006071184A1 Aryl sulphonamide modulators |
| 07/06/2006 | WO2006071138A1 Tritium-traced saxitoxin dihydrochloride and method for the production thereof |
| 07/06/2006 | WO2006071095A1 Quinazoline derivatives for the treatment and prevention of diabetes and obesity |
| 07/06/2006 | WO2006071079A1 Quinazoline derivatives for inhibiting cancer cell growth and method for the preparation thereof |
| 07/06/2006 | WO2006071077A1 Complex formulation of 3-hydroxy-3-methyl glutaryl coa reductase inhibitor and antihypertensive agent, and process for preparing same |
| 07/06/2006 | WO2006071035A1 Novel ([1,3]thiazolo[5,4-b]pyridin-2-yl)-2-carboxamide derivatives |
| 07/06/2006 | WO2006070984A1 Novel benzopyran derivatives having inhibitory activities against liver fibrosis and cirrhosis and their pharmaceutical uses |
| 07/06/2006 | WO2006070943A1 Condensed imidazole compound and use thereof |
| 07/06/2006 | WO2006070937A1 Drugs for the treatment and/or prophylaxis of gastroparesis symptom |
| 07/06/2006 | WO2006070934A1 Crystal of bicyclic fused heterocyclic derivative, process for production thereof, and use thereof |
| 07/06/2006 | WO2006070930A1 Method for stabilizing anti-dementia drug |
| 07/06/2006 | WO2006070927A1 Pyrimidinylisoxazol derivative |
| 07/06/2006 | WO2006070902A1 Method for producing l-biopterin |
| 07/06/2006 | WO2006070883A1 Quercetin glycoside composition and method of preparing the same |
| 07/06/2006 | WO2006070878A1 Carboxylic acid derivative or salt thereof |
| 07/06/2006 | WO2006070874A1 Hypoxic response promoter |
| 07/06/2006 | WO2006070873A1 Adiponectin inducer or secretagogue |
| 07/06/2006 | WO2006070856A1 Sesamin/episesamin compositions |
| 07/06/2006 | WO2006070806A1 Novel benzimidazole compound and medicinal composition containing the compound |
| 07/06/2006 | WO2006070781A1 Matrix-type controlled release preparation comprising basic substance or salt thereof, and process for production of the same |
| 07/06/2006 | WO2006070742A1 Tolerance development inhibitor for narcotic analgesic agent |
| 07/06/2006 | WO2006070735A1 Stable granular pharmaceutical composition of solifenacin or its salt |
| 07/06/2006 | WO2006070726A1 N-acetylglucosamine tablet disintegrating in oral cavity and process for producing the same |
| 07/06/2006 | WO2006070718A1 Drugs for diseases accompanying changes in total bile acid pool or lipid metabolism disorders and method of screening these drugs |
| 07/06/2006 | WO2006070705A1 Intraoral disintegration type solid preparation containing povidone iodine |
| 07/06/2006 | WO2006070673A1 Indometacin-containing adhesive patch |
| 07/06/2006 | WO2006070672A1 Hydrous adhesive patch |
| 07/06/2006 | WO2006070671A1 12-position substituted mutilin derivative |
| 07/06/2006 | WO2006070618A1 Catecholamine regulator and foods, drinks, food additives and drugs containing the same |
| 07/06/2006 | WO2006070406A1 Bilayer tablets of oxcarbazepine for controlled delivery and a process of preparation thereof |
| 07/06/2006 | WO2006070394A1 Substituted carbamic acid quinolin-6-yl esters useful as acetylcholinesterase inhibitors |
| 07/06/2006 | WO2006070393A1 SYNERGISTIC COMBINATION KIT OF α,ß-ARTEETHER, SULFADOXIN AND PYMETHAMINE FOR TREATMENT OF SEVERE/MULTI-DRUG RESISTANT CEREBRAL MALARIA |
| 07/06/2006 | WO2006070385A1 2-alkyl/aryl sulphonyl-1,2,3,4-tetrahydro-9h-pyrido (3,4-b) indole-3-carboxylic acid esters/amides useful as antithrombotic agents |
| 07/06/2006 | WO2006070381A1 Amino-functionalized 1,2,4-trioxanes useful as anti-malarial agents and process for preparation thereof |
| 07/06/2006 | WO2006070380A1 Pyrrolo [2, 1-c] [1, 4] benzodiazepine-anthraquinone conjugates useful as antitumour agents |
| 07/06/2006 | WO2006070349A2 Novel process for preparing pramipexole and its optical isomeric mixture by reduction with sodium triacetoxyborohydride |